Twenty-nine patients (39.7%) had prostate cancer diagnosed following routine PSA screening, among whom, 37.9% had symptoms on direct questioning and almost half (48.3%) had screening PSA value greater than 20 ng/mL. The gene discussed is KLK3; the disease is prostate carcinoma.